We would love to hear your thoughts about our site and services, please take our survey here.
Oleric, we have the science that Cath invented and we have enough going on along with future opportunities to probably last us a lifetime. So if you want to argue about semantics, fill ya boots but its a moot point. Shall we monetise the opportunities we have currently, which are many, before worrying about new science we may need in another 20 or 30 years time!
From Cavendish 2/2/24:
"Sales channels Dermatonics distributes its products via five sales channels, offering diversified revenue streams and generates sales in the UK, Portugal, Spain, the Baltics, and Vietnam."
No Mention of the Kingdom of Saudi Arabia.
From the rns 20/2/24
Will Pugh, Vice President of International Development for the Umesh Modi Group said:
"We are delighted to be ready to launch the Pheet and Dermatonics products."
Pheet and Dermatonics, which would suggest two different lines of products.
Looks like Modi are full steam ahead with our products. Posted 21/3/24
https://www.instagram.com/aldawaacare/p/C4xMdQER1pk/
https://www.al-dawaa.com.sa/en-about-aldawaa/
Thomas, you do know when you buy an asset it has to be paid for?
The foot balm has massive potential, for e.g. have you done any research on Modi, latest figures I can find say annual turnover of $550m and they have launched our foot balm in six countries with a sales force of 1200.
If you think sbtx is a joke and Croda will buy it for peanuts, why dont you sell up, even better short it. Let's see how that works out for you!
Bazzaman, if you want Stuart to answer a question you would do well to direct it toward investor relations, not post it on a discussion board.
Also, why is it ok for you to get personal but not Madabout? You cant have it both ways.
Of course you dont.
It wasn't a material additions, omissions (redaction ) or misrepresentations in anyway shape or form.
There is nothing to defend because nothing has happened. If it botherers you so much why dont you go and report them to AIM regulation and see how that goes.
Anyway as Mark Twain said “Never argue with stupid people, they will drag you down to their level and then beat you with experience.”
See Ya.
It's irrelevant. We already know it works, they are just validating the enhanced enhancements if you like. If it's a positive response they charge price A, if it isn't they charge price B. This has always been known since the trials have started, it doesn't change the complexion of anything (apart from your skin!) You dont know the results of a trial until you have done the trial, hence “in case of positive responses” translated to, "if we get positive results."
Nick, look, your questions whatever they were caused a sequence of events that ultimately led to SA being asked/instructed not to do behind the paywall interviews. Irrespective of if that was your objective or not, that’s what happened and you instigated it. Own it.
Thomas, nobody knows what Friday will bring, let’s just wait and see what’s in the interims. I understand the frustration but this constant doom and gloom isn’t helpful, if you feel that hostile towards the company and management you know what you need to do.
Thomas, SOH, I dont care about, Cath, not at all. This has been on the cards for a while read the rns, unless you think it is all smoke and mirrors of course! We have years of opportunity with what Cath has invented, the science is the science, nothing changes that not even a death spiral, which by the way, has enabled us to acquire what looks like a very good business which has already opened doors into India etc.
You need to take a chill pill, remember, SOH was the man that said he would commercialise sweetbiotix early 2017, things dont always go to plan.
Dire, you are half right. SOH sold down to about 13.1% (800,000) in Dec/Jan, but then the last conversation diluted him to about 12.94% which triggered a TR1. He was trying to be stealthy but got caught out, again!
Leapfroggy, I have the same contact as any other investor wishes to have. But I can answer the question for you, it's an unanswerable question, there are too many moving parts.
In this instance, if in the interims on Friday there is nothing of substance and they decide to dump we could go too 5p. If there is a little substance any dumps could be soaked up and we could stay where we are. If it is fantastic and they decide to dump we would still head up. Or any variable of any of the above, as I say unanswerable.
Anyway, I wouldn’t trust a word that comes out of Macquarie or CLG, plus there was threshold stipulations that would enable them to convert before that date anyway. For me the CB is what it is there is nothing I can do about it, it will churn through when it churns through.
Your down side is 2.5p your upside is ?????, you decide what your risk reward criteria is.
Email them and air your grievances and ask the key information you require and decide if you want to invest. You cant have investor relations that everyone agrees on as everyone wants different things. Eg, I am more than happy with IR because if I ask a question, if they can they answer it.